PMID: 42334436

Semaglutide for Primary Prevention of Major Adverse Cardiac and Cerebrovascular Events in Patients with Type 2 Diabetes and Comorbid Rheumatoid Arthritis: A Target-Trial Emulation.

Malik Farheen, Shah Mandar, Chang Yu, Chowdhury Ishmum, Mangalesh Sridhar, Morgan Ahmed Ashraf, Pascal Ezerioha, Modak Vishakha, Lebovics Nachum, Adhikari Suraj

European heart journal. Cardiovascular pharmacotherapy · 2026

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.